Login / Signup

Vincristine therapy for severe and refractory immune thrombocytopenia following COVID-19 vaccination.

Kei SaitoSatoshi IchikawaShunsuke HattaYuna KatsuokaHideo HarigaeTohru Izumi
Published in: Annals of hematology (2021)
Keyphrases
  • coronavirus disease
  • sars cov
  • early onset
  • respiratory syndrome coronavirus
  • drug induced